Ledger.Open graph →
SEC Form D · filed December 30, 2022

Launchpad Therapeutics, Inc

Offering
$30.0M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Alexander Mayweg · San Diego, CAExec · DirectorAli Behbahani · South San Francisco, CADirectorAli Behbahani · Timonium, MDDirectorAnna Kohlmann · CAMBRIDGE, MAExecAlexander Mayweg · San Diego, CAExec · DirectorAli Behbahani · Seattle, WADirectorAnna Kohlmann · CAMBRIDGE, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗